[
  {
    "ts": null,
    "headline": "Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?",
    "summary": "TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.",
    "url": "https://finnhub.io/api/news?id=e886c6f71ce087bad4f302fbf3400016c86ca4369be9c94adc52450827f29b78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769780640,
      "headline": "Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?",
      "id": 138306414,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.",
      "url": "https://finnhub.io/api/news?id=e886c6f71ce087bad4f302fbf3400016c86ca4369be9c94adc52450827f29b78"
    }
  }
]